These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8607158)

  • 1. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility.
    Greeno EW; Perry EH; Ilstrup SJ; Weisdorf DJ
    Transfusion; 1996 Jan; 36(1):71-4. PubMed ID: 8607158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
    Gajewski JL; Petz LD; Calhoun L; O'Rourke S; Landaw EM; Lyddane NR; Hunt LA; Schiller GJ; Ho WG; Champlin RE
    Blood; 1992 Jun; 79(11):3076-85. PubMed ID: 1586749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation.
    Salmon JP; Michaux S; Hermanne JP; Baudoux E; Gérard C; Sontag-Thull D; Fillet G; Beguin Y
    Transfusion; 1999 Aug; 39(8):824-7. PubMed ID: 10504116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility.
    Laurencet FM; Samii K; Bressoud A; Tajeddin M; Easton J; Stelling MJ; Chapuis B
    Hematol Cell Ther; 1997 Jun; 39(3):159-62. PubMed ID: 9262993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.
    Hows J; Beddow K; Gordon-Smith E; Branch DR; Spruce W; Sniecinski I; Krance RA; Petz LD
    Blood; 1986 Jan; 67(1):177-81. PubMed ID: 3079641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
    Lasky LC; Warkentin PI; Kersey JH; Ramsay NK; McGlave PB; McCullough J
    Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion of donor-type red cells as a single preparative treatment for bone marrow transplants with major ABO incompatibility.
    Nussbaumer W; Schwaighofer H; Gratwohl A; Kilga S; Schönitzer D; Nachbaur D; Niederwieser D
    Transfusion; 1995 Jul; 35(7):592-5. PubMed ID: 7631393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The devil is in the details: retention of recipient group A type 5 years after a successful allogeneic bone marrow transplant from a group O donor.
    Cooling LLW; Herrst M; Hugan SL
    Immunohematology; 2018 Jan; 33(1):19-22. PubMed ID: 29608324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
    Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors].
    Peces R; Díaz Corte C; Navascués RA
    Nefrologia; 2001; 21(4):395-401. PubMed ID: 11816517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO incompatibile graft management in pediatric transplantation.
    Balduzzi A; Bönig H; Jarisch A; Nava T; Ansari M; Cattoni A; Prunotto G; Lucchini G; Krivan G; Matic T; Kalwak K; Yesilipek A; Ifversen M; Svec P; Buechner J; Vettenranta K; Meisel R; Lawitschka A; Peters C; Gibson B; Dalissier A; Corbacioglu S; Willasch A; Dalle JH; Bader P;
    Bone Marrow Transplant; 2021 Jan; 56(1):84-90. PubMed ID: 32594103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.
    Ockelford PA; Hill RS; Nelson L; Blacklock HA; Woodfield DG; Matthews JR
    Transfusion; 1982; 22(1):62-5. PubMed ID: 7039010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Bacigalupo A; Van Lint MT; Occhini D; Margiocco M; Ferrari G; Pittaluga PA; Frassoni F; Peralvo J; Lercari G; Carubia F
    Transplantation; 1988 Jun; 45(6):1091-4. PubMed ID: 3289150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
    Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
    Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
    Mehta P; Ramprakash S; Raghuram CP; Trivedi D; Dhanya R; Agarwal RK; Faulkner L
    Ann Hematol; 2021 Aug; 100(8):2071-2078. PubMed ID: 34148110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility.
    Bolan CD; Childs RW; Procter JL; Barrett AJ; Leitman SF
    Br J Haematol; 2001 Mar; 112(3):787-95. PubMed ID: 11260085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.